Showing 481 - 500 results of 99,936 for search '(( 5 non decrease ) OR ( 5 ((((non decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.81s Refine Results
  1. 481
  2. 482
  3. 483
  4. 484

    Influenza virus infection decreases CLEC7A (Dectin1) mRNA and reduces phagocytosis of zymosan by AM. by Jieru Wang (179734)

    Published 2012
    “…<p>Panel A. Human AM were cultured and infected by PR/8 at a MOI of 0.5. …”
  5. 485
  6. 486
  7. 487
  8. 488
  9. 489

    Relationships between empty body lipid weight decrease and corrected amounts of pollutants excreted through faeces (faecal output–feed input) for TCDD (○, ●), and PCBs 153 (□, ■) and 126 (Δ, ▲) over a 57-day depuration period in ewes receiving a control well-fed and non-supplemented treatments (CTL: ○, □, Δ; <i>n</i> = 4), or an underfed and mineral oil supplemented treatment (UFMO: ●, ■, ▲; <i>n</i> = 5). by Sylvain Lerch (1494349)

    Published 2020
    “…<p>Relationships between empty body lipid weight decrease and corrected amounts of pollutants excreted through faeces (faecal output–feed input) for TCDD (○, ●), and PCBs 153 (□, ■) and 126 (Δ, ▲) over a 57-day depuration period in ewes receiving a control well-fed and non-supplemented treatments (CTL: ○, □, Δ; <i>n</i> = 4), or an underfed and mineral oil supplemented treatment (UFMO: ●, ■, ▲; <i>n</i> = 5).…”
  10. 490

    Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

    Published 2015
    “…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”
  11. 491

    Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…<b>a. RT-qPCR analysis:</b> relative TMPRSS2-ERG fusion variants III and IV mRNA levels were analysed and compared to non-treated cells. …”
  12. 492
  13. 493
  14. 494
  15. 495
  16. 496
  17. 497
  18. 498
  19. 499
  20. 500